Aldosterone synthase inhibitors
View Patent ↗This invention relates to tricyclic triazole analogs of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.
1. A compound of the formula I
or a pharmaceutically acceptable salt thereof
wherein:
X is N or C(R 6 );
R 1 is H; alkyl optionally independently substituted one or more times by halogen, —OR 7 , NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 , or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 , or —S(O) m —R 7 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ;
R 2 is H; halogen; —CN; alkyl optionally independently substituted one or more times by halogen; or cycloalkyl optionally independently substituted once or twice by alkyl or halogen;
R 3 is H; halogen; —CN; alkyl optionally independently substituted one or more times by halogen; or cycloalkyl optionally substituted once or twice by alkyl or halogen;
R 4 is H; halogen; —CN; alkyl optionally independently substituted one or more times by halogen; or cycloalkyl optionally independently substituted once or twice by alkyl or halogen;
R 5 is H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)R 7 ; —C(O)N(R 8 )(R 9 ); —C(O)OR 7 ; —N(R 11 )S(O) 2 R 7 ; —S(O) 2 N(R 8 )(R 9 ); —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), heteroaryl (optionally substituted one or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aralkyl wherein the aryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted one or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; or heteroaralkyl wherein the heteroaryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ;
R 6 is H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)N(R 8 )(R 9 ); —C(O)R 7 ; —C(O)OR 7 ; —N(R 11 )S(O) 2 R 7 ; —S(O) 2 N(R 8 )(R 9 ); —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), heteroaryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 8 or —S(O) m —R 8 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted one or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted one or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)(R 7 ), —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aralkyl wherein the aryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; heteroaralkyl wherein the heteroaryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ;
or R 5 and R 6 are joined together to form a 5-7 membered carbocyclic or heterocyclic ring that is fused to the pyridyl ring to which R 5 and R 6 are attached, wherein the ring formed by R 5 and R 6 is optionally independently substituted by 1 to 3 R 10 ;
R 7 is independently selected from the group consisting of H; alkyl optionally independently substituted one or more times by halogen, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 , aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl); cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 , aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OH, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 11 , —NR 8 R 9 , —CN, —N(R 9 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ;
R 8 is independently H or alkyl;
R 9 is independently H or alkyl;
R 10 is independently H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)N(R 7 )(R 8 ); —C(O)N(R 8 )(R 9 ); —C(O)OR 7 ; —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 1 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 8 or —S(O) m —R 8 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)(R 7 ), —C(O)N(R 7 )(R 8 ), —C(O)OR 7 or —S(O) m —R 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ;
R 11 is independently H or alkyl;
is an optional double bond;
n is 1 or 2; and
m is 0, 1 or 2.
2. The compound as defined in claim 1 or a pharmaceutically acceptable salt thereof which has the structural formula
wherein:
R 1 is H; alkyl optionally independently substituted one or more times by halogen, —OR 7 , NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 , or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 , or —S(O) m —R 7 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ;
R 2 is H; halogen; —CN; alkyl optionally independently substituted one or more times by halogen; or cyclopropyl optionally independently substituted once or twice by alkyl or halogen;
R 3 is H; halogen; —CN; alkyl optionally independently substituted one or more times by halogen; or cyclopropyl optionally independently substituted once or twice by alkyl or halogen;
R 4 is H; halogen; —CN; alkyl optionally independently substituted one or more times by halogen; or cycloalkyl optionally independently substituted once or twice by alkyl or halogen;
R 5 is H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)R 7 ; —C(O)N(R 8 )(R 9 ); —C(O)OR 7 ; —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, aryl (optionally substituted one or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), heteroaryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted one or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aralkyl wherein the aryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl); heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; or heteroaralkyl wherein the heteroaryl ring is optionally substituted one or more times independently by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ;
R 6 is H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)R 7 , —C(O)OR 7 ; —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by independently halogen, alkyl, haloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), heteroaryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 8 or —S(O) m —R 8 ; aryl optionally independently substituted one or more times independently by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)(R 11 ), —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aralkyl wherein the aryl ring is optionally independently substituted one or more times independently by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and is optionally substituted once or more times by halogen or —OR 7 ); heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; heteroaryl optionally independently substituted once or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; or heteroaralkyl wherein the heteroaryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and is optionally substituted one or more times by halogen or —OR 7 ;
or R 5 and R 6 are joined together to form a 5-7 membered carbocyclic or heterocyclic ring that is fused to the pyridyl ring to which R 5 and R 6 are attached, wherein the ring formed by R 5 and R 6 is optionally independently substituted by 1 to 3 R 10 ;
R 7 is independently selected from the group consisting of H; alkyl optionally independently substituted one or more times by halogen, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 , —S(O) m —R 11 , aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl); heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl); cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OH, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 11 , —NR 8 R 9 , —CN, —N(R 9 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ;
R 8 is independently H or alkyl;
R 9 is independently H or alkyl;
R 10 is independently H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)N(R 7 )(R 8 ); —C(O)N(R 8 )(R 9 ); —C(O)OR 7 ; —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 8 or —S(O) m —R 8 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)(R 7 ), —C(O)N(R 7 )(R 8 ), —C(O)OR 7 or —S(O) m —R 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; and
R 11 is independently H or alkyl;
n is 1 or 2;
m is 0, 1 or 2.
3. The compound as defined in claim 1 or a pharmaceutically acceptable salt thereof which has the structural formula
wherein
R 1 is H, alkyl, haloalkyl, cycloalkyl, phenyl, halo-substituted phenyl, alkyl-substituted phenyl, heteroaryl, alkyl-substituted heteroaryl, cyclopropyl-substituted heteroaryl,
where heteroaryl is selected from the group consisting of pyridyl, pyrazinyl, furanyl, thienyl, pyrimidinyl, pyridone, isoxazolyl, isothiazolyl, oxazolyl, thiazolyl, pyrazolyl, oxadiazolyl, tetrazolyl, pyrimidyl, furazanyl, pyrrolyl, pyrazolyl, triazolyl, 1,2,4-thiadiazolyl, pyrazinyl, pyridazinyl, indolyl, azaindolyl, benzimidazolyl, benzothienyl, quinolinyl, imidazolyl, thienopyridyl, quinazolinyl, thienopyrimidyl, pyrrolopyridyl, imidazopyridyl, isoquinolinyl, benzoazaindolyl, 1,2,4-triazinyl, benzoxazolyl, benzothiazolyl, pyridopyrimidinyl or 7-azaindolyl.
4. The compound as defined in claim 3 or a pharmaceutically acceptable salt thereof wherein;
R 5 is H, —C(O)OR 7 , —S(O) 2 R 7 , or oxetanyl and R 7 is independently C 1 -C 4 -alkyl or phenyl; and
R 6 is H.
5. The compound as defined in claim 3 or a pharmaceutically acceptable salt thereof wherein:
R 5 is H, halogen, alkyl, haloalkyl, N(R 11 )SO 2 R 7 or —C(O)R 7 , where R 7 is independently C 1 -C 4 -alkyl or phenyl; and
R 6 is H, alkyl or cycloalkyl.
6. The compound as defined in claim 3 or a pharmaceutically acceptable salt thereof, wherein
R 5 is a group of the formulae:
where:
R a is —C 1 -C 4 -alkyl optionally substituted with 1 to 3 —F;
R b is halogen, —OH, or —C 1 -C 4 -alkyl optionally substituted with 1 to 3 —F;
R c is halogen, —OH, —C 1 -C 4 -alkyl substituted with 1 to 3 —F or —O—C 1 -C 4 -alkyl substituted with 1 to 3 —F, —O—C 1 -C 4 -alkyl optionally substituted with 1 to 3 —F, —C(O)O—C 1 -C 4 -alkyl, —S(O) 2 —C 1 -C 4 -alkyl, —C(O)N(C 1 -C 4 -alkyl)(C 1 -C 4 -alkyl), cyclopropyl or heteroaryl, which is optionally substituted by C 1 -C 4 alkyl, phenyl, C 1 -C 4 -alkyl substituted with 1 to 3 —F or cyclopropyl, and the heteroaryl ring is triazole or oxadiazole; and
R d is —C 1 -C 4 -alkyl, —C(O)O—C 1 -C 4 -alkyl, —S(O) 2 —C 1 -C 4 -alkyl, or heteroaryl, which is optionally substituted by C 1 -C 4 alkyl, phenyl, C 1 -C 4 -alkyl substituted with 1 to 3 —F or cyclopropyl, and the heteroaryl ring is triazole or oxadiazole; and
R 6 is H or alkyl.
7. The compound as defined in claim 2 or a pharmaceutically acceptable salt thereof which has the structural formula
wherein
R 1 is H, alkyl, haloalkyl, cycloalkyl, phenyl, halo-substituted phenyl, alkyl-substituted-substituted phenyl, heteroaryl, alkyl-substituted heteroaryl, cyclopropyl-substituted heteroaryl, where heteroaryl is selected from the group consisting of pyridyl, pyrazinyl, furanyl, thienyl, pyrimidinyl, pyridone, isoxazolyl, isothiazolyl, oxazolyl, thiazolyl, pyrazolyl, oxadiazolyl, tetrazolyl, pyrimidyl, furazanyl, pyrrolyl, pyrazolyl, triazolyl, 1,2,4-thiadiazolyl, pyrazinyl, pyridazinyl, indolyl, azaindolyl, benzimidazolyl, benzothienyl, quinolinyl, imidazolyl, thienopyridyl, quinazolinyl, thienopyrimidyl, pyrrolopyridyl, imidazopyridyl, isoquinolinyl, benzoazaindolyl, 1,2,4-triazinyl, benzoxazolyl, benzothiazolyl, pyridopyrimidinyl, or 7-azaindolyl; and
R 6 is H.
8. The compound as defined in claim 2 or a pharmaceutically acceptable salt thereof which has the structural formula
wherein R 1 is H, alkyl, haloalkyl, cycloalkyl, phenyl, halo-substituted phenyl, alkyl-substituted-substituted phenyl, heteroaryl, alkyl-substituted heteroaryl, cyclopropyl-substituted heteroaryl, where heteroaryl is selected from the group consisting of pyridyl, pyrazinyl, furanyl, thienyl, pyrimidinyl, pyridone, isoxazolyl, isothiazolyl, oxazolyl, thiazolyl, pyrazolyl, oxadiazolyl, tetrazolyl, pyrimidyl, furazanyl, pyrrolyl, pyrazolyl, triazolyl, 1,2,4-thiadiazolyl, pyrazinyl, pyridazinyl, indolyl, azaindolyl, benzimidazolyl, benzothienyl, quinolinyl, imidazolyl, thienopyridyl, quinazolinyl, thienopyrimidyl, pyrrolopyridyl, imidazopyridyl, isoquinolinyl, benzoazaindolyl, 1,2,4-triazinyl, benzoxazolyl, benzothiazolyl, pyridopyrimidinyl, or 7-azaindolyl R 10 is independently alkyl or halo;
and a is 0, 1 or 2.
9. A compound of formula VI
or a pharmaceutically acceptable salt thereof
wherein
R 1 is independently H or alkyl;
R 5 is H; halogen; —CN; —OR 7 , —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)R 7 ; —C(O)N(R 8 )(R 9 ); —C(O)OR 7 ; —N(R 11 )S(O) 2 R 7 ; —S(O) 2 N(R 8 )(R 9 ); —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 ; —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 ; —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), heteroaryl (optionally substituted one or twice by halogen, alkyl, haloalkyl, cycloalkyl or aryl), —OR 7 ; —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 ; —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; aralkyl wherein the aryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted one or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 , heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 ; or heteroaralkyl wherein the heteroaryl ring is optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 7 or —S(O) m —R 7 and the alkyl chain is straight or branched and optionally substituted one or more times by halogen or —OR 7 ;
or R 5 and R 6 are joined together to form a 5-7 membered carbocyclic or heterocyclic ring that is fused to the pyridyl ring to which R 5 and R 6 are attached, wherein the ring formed by R 5 and R 6 is optionally independently substituted by 1 to 3 R 10 ;
R 7 is independently selected from the group consisting of H; alkyl optionally independently substituted one or more times by halogen, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 , aryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl), heteroaryl (optionally substituted once or twice by halogen, alkyl, or haloalkyl); cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 , aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OH, —OR 11 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 11 , —NR 8 R 9 , —CN, —N(R 9 )C(O)R 11 , —C(O)N(R 8 )(R 9 ), —C(O)OR 11 or —S(O) m —R 11 ;
R 8 is independently H or alkyl;
R 9 is independently H or alkyl;
R 10 is independently H; halogen; —CN; —OR 7 ; —NR 8 R 9 ; —N(R 11 )C(O)R 7 ; —C(O)N(R 7 )(R 8 ); —C(O)N(R 8 )(R 9 ); —C(O)OR 7 ; —S(O) m —R 7 ; alkyl optionally independently substituted one or more times by halogen, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ); —C(O)OR 7 or —S(O) m R 7 ; cycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —NR 8 R 9 , —CN, —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ), —C(O)OR 8 or —S(O) m —R 8 ; aryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)(R 7 ), —C(O)N(R 7 )(R 8 ), —C(O)OR 7 or —S(O) m —R 7 ; heterocycloalkyl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, —OR 7 , —CN, —NR 8 R 9 —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ); —C(O)OR 7 or —S(O) m —R 7 ; or heteroaryl optionally independently substituted one or more times by halogen, alkyl, haloalkyl, cycloalkyl, —OR 7 , —CN, —NR 8 R 9 , —N(R 11 )C(O)R 7 , —C(O)N(R 8 )(R 9 ); —C(O)OR 7 or —S(O) m —R 7 ;
R 11 is independently H or alkyl;
m is 0, 1 or 2;
R a′ is at the 6-, 8-, and/or 9-positions and is independently halogen, CN, alkyl or cycloalkyl; and
b is 1, 2 or 3.
10. The compound as defined in claim 9 or a pharmaceutically acceptable salt thereof wherein
R 5 is hydrogen, halogen, —CN, alkyl, haloalkyl, cycloalkyl, hydroxy-substituted alkyl, hydroxy substituted-haloalkyl, alkoxy, haloalkoxy, phenyl, —C(O)R 7 or —N(H)SO 2 R 7 , where R 7 is alkyl or phenyl; and
R 6 is hydrogen, —CN, alkyl, haloalkyl, cycloalkyl, cyano, hydroxy-substituted alkyl, alkoxy, haloalkoxy or —C(O)R 7 , where R 7 is alkyl or phenyl.
11. The compound as defined in claim 9 or a pharmaceutically acceptable salt thereof wherein
R 5 is a group of the formulae:
where:
R a is —C 1 -C 4 -alkyl optionally substituted with 1 to 3 —F;
R b is halogen, —OH, or —C 1 -C 4 -alkyl optionally substituted with 1 to 3 —F;
R c is halogen, —OH, —C 1 -C 4 -alkyl substituted with 1 to 3 —F or —O—C 1 -C 4 -alkyl substituted with 1 to 3 —F, —O—C 1 -C 4 -alkyl optionally substituted with 1 to 3 —F, —C(O)O—C 1 -C 4 -alkyl, —S(O) 2 —C 1 -C 4 -alkyl, —C(O)N(C 1 -C 4 -alkyl)(C 1 -C 4 -alkyl), cyclopropyl or heteroaryl, which is optionally substituted by C 1 -C 4 alkyl, phenyl, C 1 -C 4 -alkyl substituted with 1 to 3 —F or cyclopropyl, and the heteroaryl ring is triazole or oxadiazole; and
R d is —C 1 -C 4 -alkyl, —C(O)O—C 1 -C 4 -alkyl, —S(O) 2 —C 1 -C 4 -alkyl, or heteroaryl, which is optionally substituted by C 1 -C 4 alkyl, phenyl, C 1 -C 4 -alkyl substituted with 1 to 3 —F or cyclopropyl, and the heteroaryl ring is triazole or oxadiazole, and
R 6 is H or alkyl.
12. A compound of formula VII
or a pharmaceutically acceptable salt thereof
wherein
R 1 is independently H or alkyl;
R a′ is at the 6-, 8-, and/or 9-positions and is independently halogen, CN, alkyl or cycloalkyl,
R 10 is alkyl or halo,
Y is N or CH;
a is 0 or 1 and
b is 1, 2 or 3.
13. The compound as defined in claim 9 that has the formula:
or a pharmaceutically acceptable salt thereof.
14. The compound as defined in claim 9 that has the formula:
or a pharmaceutically acceptable salt thereof.
15. The compound selected from the group consisting of
7-[5-(1-ethylcyclopropyl)pyridin-3-yl]-1-methyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinoline;
7-[5-[2-methyl-1-(trifluoromethoxy)propan-2-yl]pyridin-3-yl]-4,5-dihydro[1,2,4]triazolo[4,3-a]quinoline;
7-(isoquinolin-4-yl)-1-methyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinoline;
7-[5-(2-methoxypropan-2-yl)pyridin-3-yl]-4,5-dihydro[1,2,4]triazolo[4,3-a]quinoline;
methyl 1-[5-(4,5-dihydro[1,2,4]triazolo[4,3-a]quinolin-7-yl)pyridin-3-yl]cyclopropanecarboxylate;
1-methyl-7-[5-(phenylsulfonyl)pyridin-3-yl]-4,5-dihydro[1,2,4]triazolo[4,3-a]quinoline;
7-{5-[2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)propan-2-yl]pyridin-3-yl}-4,5-dihydro[1,2,4]triazolo[4,3-a]quinoline;
methyl 5-(1-methyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolin-7-yl)pyridine-3-carboxylate;
or a pharmaceutically acceptable salt thereof.
16. The compound selected from the group consisting of
9-chloro-1-methyl-7-(4-(trifluoromethyl)pyridin-3-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
8-chloro-7-(isoquinolin-4-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-chloro-7-(4-ethyl-5-fluoropyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
8-fluoro-7-(4-methoxy-5-methylpyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-chloro-7-(4-cyclopropylpyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-chloro-7-(5-chloro-4-methylpyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-chloro-7-(4-ethyl-5-fluoropyridin-3-yl)-8-fluoro-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-chloro-8-fluoro-7-(5-fluoro-4-methylpyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
1-(3-(9-chloro-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-5-fluoropyridin-4-yl]ethanone;
9-chloro-7-(5-fluoro-4-isopropylpyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline
or a pharmaceutically acceptable salt thereof.
17. The compound selected from the group consisting of:
9-fluoro-7-(5-fluoro-pyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-fluoro-7-(5-methoxy-pyridin-3-yl)-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
1-[5-(9-fluoro-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-pyridin-3-yl]-ethanol;
1-[5-(9-fluoro-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-pyridin-3-yl]-ethanone;
9-fluoro-1-methyl-7-(5-trifluoromethyl-pyridin-3-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-fluoro-1-methyl-7-(5-phenyl-pyridin-3-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-fluoro-1-methyl-7-(4-methyl-pyridin-3-yl)-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-fluoro-7-isoquinolin-4-yl-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-fluoro-1-methyl-7-pyridin-3-yl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
9-fluoro-7-pyridin-3-yl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
8-fluoro-1-methyl-7-pyridin-3-yl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline
8-fluoro-7-pyridin-3-yl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline
or a pharmaceutically acceptable salt thereof.
18. The compound selected from the group consisting of:
7-(4-ethyl-5-fluoropyridin-3-yl)-9-fluoro-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
7-(4-ethyl-5-fluoropyridin-3-yl)-8,9-difluoro-1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline;
or a pharmaceutically acceptable salt thereof.
19. A pharmaceutical composition comprising a therapeutically effective amount of at least one compound of Formula I as defined in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
20. A pharmaceutical composition comprising a therapeutically effective amount of at least one compound of Formula I as defined in claim 1 or a pharmaceutically acceptable salt thereof, a therapeutically effective amount of at least one additional therapeutic agent and a pharmaceutically acceptable carrier.